Estimates Revisions Evotec SE Deutsche Boerse AG
Stocks
EVT
DE0005664809
Biotechnology & Medical Research
|
Market Closed -
Deutsche Boerse AG
15:41:48 2026-09-11 EDT
|
5-day change | 1st Jan Change | ||
| 2.974 EUR | -0.87% |
|
-7.12% | -45.53% |
| 09-09 | Evotec Initiates Phase 1 Trial of Potential Smallpox, Mpox Treatment | MT |
| 09-09 | Evotec Commences Early-stage Study of Potential Orthopoxvirus Therapy | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Data source:
Evotec SE(EVT)
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Data source:
Evotec SE(EVT)
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
| - | ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
Data source:
Evotec SE(EVT)
EBIT
Dividend / Share (DPS)
Data source:
Evotec SE(EVT)
Cash or Net Debt
- Stock Market
- Stocks
- EVT Stock
- EVT Stock
- Consensus Evotec SE
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
















